Disposable Hypodermic Syringes Market

Disposable hypodermic syringes market to exhibit dynamic growth during the forecast period. 

The global disposable hypodermic syringes market is witnessing steady growth, expected to grow at a CAGR of 6.2%. Worldwide, the increasing prevalence of diabetes, multiple sclerosis, and numerous lifestyle diseases will drive overall market growth. Globally, the rising number of surgeries, increased growth of biologics, advancement in hypodermic syringes with fixed dosage, low-cost medical devices, and decreased microbial contamination risk along with reduced medication errors are key factors driving the overall growth of the disposable hypodermic syringes market. Additionally, enhanced R&D for disposable syringes, growth in the general and specialized syringes, increased physician visits, and increased product penetration in the hospitals and clinics will further spur revenue growth in the near future. 

Market Synopsis

Insulin syringes are expected to register higher growth by the end of 2027 

The increasing prevalence of Type 1 diabetes and Type 2 diabetes in children and adults will upsurge the demand for insulin delivery. According to the recent edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017, around 424.9 million people were living with diabetes worldwide, and estimated to increase by 48% by the end of 2045. Additionally, a high prevalence of multiple sclerosis and other lifestyle diseases will upsurge the overall demand in the near future. Increased use of single-use dental hypodermic syringes for daily operations will drive revenue growth. Utilization of multishot needle syringes and extraction syringes show steady growth during the forecast period due to their ease of operation, enhanced safety, low cost, and availability. 

Diabetic care centers segment to witness a significant CAGR 

Expansion of diabetes care and services, along with increased awareness about overall health management on a global scale, will drive the overall growth of the market. Top institutes and organizations in collaboration with healthcare companies are expanding their services in untapped markets, e.g., the American Association of Diabetes Educators, NCPA Foundation, and others. Increased preference for disposable hypodermic syringes in hospitals and clinics compared to traditional syringes at low cost, along with no chance of cross-contamination, will show promising growth on a global scale. Increasing hospital admissions and expanding outpatient clinics and centers will increase the volume of disposable hypodermic syringes, mainly for insulin delivery, vaccination, anesthesia administration, and extraction of blood. 

Increased research and development with a strong product portfolio in the developed regions 

Major players in the disposable hypodermic syringes market are Becton, Dickinson and Company, Smiths Medical, Terumo Corporation, Albert David Ltd., Nipro Corporation, Medtronic plc, Thermo Fisher Scientific, Gerresheimer AG, B. Braun Medical Inc., Hindustan Syringes & Medical Devices Limited, Changzhou Holinx Industries Co., Ltd., CODAN Medizinische Geräte GmbH & Co KG, ISCON SURGICAL LTD., and others. In addition, innovative product launches with higher patient safety & compatibility, low-cost products, partnerships, new technology expansion, and improved R&D on disposable syringes will further spur revenue growth globally.  

Historical & Forecast Period

This study report represents an analysis for each segment from 2017 to 2027, considering 2018to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027. 

Report Scope by Segments

Market Segmentation 

Segmentation Type Segment (2017–2027; US$ Mn)

 • Insulin Syringes

 • Multishot Needle Syringes

 • Extraction Syringes

 • Dental Syringes

 End User Segment (2017–2027; US$ Mn)

 • Hospitals and Clinics

 • Diagnostic Laboratories

 • Diabetic Care Centers

 • Others

 Geography Segment (2017–2027; US$ Mn)

 • North America (U.S. and Rest of North America)

 • Europe (U.K., Germany, France, and Rest of Europe)

 • Asia Pacific (Japan, China, India, and Rest of Asia Pacific)

 • Rest of World (Middle East & Africa (MEA), Latin America)

The present report also figures out qualitative and quantitative market evaluation factors such as key market trends, market drivers, restraints, and opportunities that provide a better understanding of the global market. Moreover, the global report also encompasses a graphical illustration of the competitive landscape based on their market value, business strength, product portfolio, and strategies such as new product launches, technology expansions, acquisitions, licensing agreements, and partnerships.

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global DHS Market
2.2. Global DHS Market, by Type, 2018 (US$ Mn)
2.3. Global DHS Market, by End User, 2018 (US$ Mn)
2.4. Global DHS Market, by Geography, 2018 (US$ Mn)

3. Market Dynamics
3.1. Introduction
3.1.1. Global DHS Market Value, 2017-2027, (US$ Mn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market Positioning of Key Players, 2018
3.4.1. Major Strategies Adopted by Key Players

4. Global Disposable Hypodermic Syringes (DHS) Market, by Type , 2017-2027 (US$ Mn)
4.1. Overview
4.2. Insulin Syringes
4.3. Multishot Needle Syringes
4.4. Extraction Syringes
4.5. Dental Syringes

5. Global Disposable Hypodermic Syringes (DHS) Market, by End User, 2017-2027 (US$ Mn)
5.1. Hospitals and Clinics
5.2. Diagnostic Laboratories
5.3. Diabetic Care Centers
5.4. Others (Veterinary Clinics, Blood Collection Centers)

6. North America Disposable Hypodermic Syringes (DHS) Market Analysis, 2017-2027 (US$ Mn)
6.1. Overview
6.1.1. North America DHS Market Value and Growth, 2017-2027, (US$ Mn)
6.2. North America DHS Market Value, By Type, 2017-2027 (US$ Mn)
6.2.1. Insulin Syringes
6.2.2. Multishot Needle Syringes
6.2.3. Extraction Syringes
6.2.4. Dental Syringes
6.3. North America DHS Market Value, By End User, 2017-2027 (US$ Mn)
6.3.1. Hospitals and Clinics
6.3.2. Diagnostic Laboratories
6.3.3. Diabetic Care Centers
6.3.4. Others (Veterinary Clinics, Blood Collection Centers)
6.4. North America DHS Market Value, By Region/Country, 2017-2027 (US$ Mn)
6.4.1. Market Analysis
6.4.2. U.S.
6.4.3. Rest of North America

7. Europe Disposable Hypodermic Syringes (DHS) Market Analysis, 2017-2027 (US$ Mn)
7.1. Overview
7.1.1. Europe DHS Market Value and Growth, 2017-2027, (US$ Mn)
7.2. Europe DHS Market Value, By Type, 2017-2027 (US$ Mn)
7.2.1. Insulin Syringes
7.2.2. Multishot Needle Syringes
7.2.3. Extraction Syringes
7.2.4. Dental Syringes
7.3. Europe DHS Market Value, By End User, 2017-2027 (US$ Mn)
7.3.1. Hospitals and Clinics
7.3.2. Diagnostic Laboratories
7.3.3. Diabetic Care Centers
7.3.4. Others (Veterinary Clinics, Blood Collection Centers)
7.4. Europe DHS Market Value, By Region/Country, 2017-2027 (US$ Mn)
7.4.1. Market Analysis
7.4.2. U.K.
7.4.3. Germany
7.4.4. France
7.4.5. Rest of Europe

8. Asia Pacific Disposable Hypodermic Syringes (DHS) Market Analysis, 2017-2027 (US$ Mn)
8.1. Overview
8.1.1. Asia Pacific DHS Market Value and Growth, 2017-2027, (US$ Mn)
8.2. Asia Pacific DHS Market Value, By Type, 2017-2027 (US$ Mn)
8.2.1. Insulin Syringes
8.2.2. Multishot Needle Syringes
8.2.3. Extraction Syringes
8.2.4. Dental Syringes
8.3. Asia Pacific DHS Market Value, By End User, 2017-2027 (US$ Mn)
8.3.1. Hospitals and Clinics
8.3.2. Diagnostic Laboratories
8.3.3. Diabetic Care Centers
8.3.4. Others (Veterinary Clinics, Blood Collection Centers)
8.4. Asia Pacific DHS Market Value, By Region/Country, 2017-2027 (US$ Mn)
8.4.1. Market Analysis
8.4.2. Japan
8.4.3. China
8.4.4. India
8.4.5. Rest of Asia Pacific

9. Rest of the World Disposable Hypodermic Syringes (DHS) Market Analysis, 2017-2027 (US$ Mn)
9.1. Overview
9.1.1. Rest of the World DHS Market Value and Growth, 2017-2027, (US$ Mn)
9.2. Rest of the World DHS Market Value, By Type, 2017-2027 (US$ Mn)
9.2.1. Insulin Syringes
9.2.2. Multishot Needle Syringes
9.2.3. Extraction Syringes
9.2.4. Dental Syringes
9.3. Rest of the World DHS Market Value, By End User, 2017-2027 (US$ Mn)
9.3.1. Hospitals and Clinics
9.3.2. Diagnostic Laboratories
9.3.3. Diabetic Care Centers
9.3.4. Others (Veterinary Clinics, Blood Collection Centers)
9.4. Rest of the World DHS Market Value, By Region, 2017-2027 (US$ Mn)
9.4.1. Market Analysis
9.4.2. Middle East & Africa
9.4.3. Latin America

10. Company Profiles
10.1. Becton, Dickinson and Company
10.2. Smiths Medical
10.3. Terumo Corporation
10.4. Albert David Ltd.
10.5. Nipro Corporation
10.6. Medtronic plc
10.7. Thermo Fisher Scientific
10.8. Gerresheimer AG
10.9. B. Braun Medical Inc.
10.10. Hindustan Syringes & Medical Devices Limited
10.11. Changzhou Holinx Industries Co., Ltd.
10.12. CODAN Medizinische Geräte GmbH & Co KG
10.13. ISCON SURGICALS LTD.

List of Figures

FIG. 1 Global Disposable Hypodermic Syringes (DHS) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global DHS Market Segmentation
FIG. 4 Global DHS Market, by Type, 2018 (US$ Mn)
FIG. 5 Global DHS Market, by End User, 2018 (US$ Mn)
FIG. 6 Global DHS Market, by Geography, 2018 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Geography, 2018
FIG. 8 Global Market Positioning of Key DHS Market Manufacturers, 2018
FIG. 9 Global DHS Market Value Share, by Type, 2018 & 2027 (Value %)
FIG. 10 Global DHSs Market for Insulin Syringes, 2017–2027 (US$ Mn)
FIG. 11 Global DHSs Market for Multishot Needle Syringes, 2017–2027 (US$ Mn)
FIG. 12 Global DHSs Market for Extraction Syringes, 2017–2027 (US$ Mn)
FIG. 13 Global DHSs Market for Dental Syringes, 2017–2027 (US$ Mn)
FIG. 14 Global DHS Market Value Share, by End User, 2018 & 2027 (Value %)
FIG. 15 Global DHSs Market for Hospitals and Clinics, 2017–2027 (US$ Mn)
FIG. 16 Global DHSs Market for Diagnostic Laboratories, 2017–2027 (US$ Mn)
FIG. 17 Global DHSs Market for Diabetic Care Centers, 2017–2027 (US$ Mn)
FIG. 18 Global DHSs Market for Others (Veterinary Clinics, Blood Collection Centers), 2017–2027 (US$ Mn)
FIG. 19 North America DHS Market, 2017–2027 (US$ Mn)
FIG. 20 Europe DHS Market, 2017–2027 (US$ Mn)
FIG. 21 Asia Pacific DHS Market, 2017–2027 (US$ Mn)
FIG. 22 RoW DHS Market, 2017–2027 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Disposable Hypodermic Syringes (DHS) Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 Global DHS Market, by Type, 2017–2027 (US$ Mn)
TABLE 5 Global DHS Market, by End User, 2017–2027 (US$ Mn)
TABLE 6 Global DHS Market, by Geography, 2017–2027 (US$ Mn)
TABLE 7 North America DHS Market, by Type, 2017–2027 (US$ Mn)
TABLE 8 North America DHS Market, by End User, 2017–2027 (US$ Mn)
TABLE 9 North America DHS Market, by Country, 2017–2027 (US$ Mn)
TABLE 10 Europe DHS Market, by Type, 2017–2027 (US$ Mn)
TABLE 11 Europe DHS Market, by End User, 2017–2027 (US$ Mn)
TABLE 12 Europe DHS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 13 Asia Pacific DHS Market, by Type, 2017–2027 (US$ Mn)
TABLE 14 Asia Pacific DHS Market, by End User, 2017–2027 (US$ Mn)
TABLE 15 Asia Pacific DHS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 16 Rest of the World DHS Market, by Type, 2017–2027 (US$ Mn)
TABLE 17 Rest of the World DHS Market, by End User, 2017–2027 (US$ Mn)
TABLE 18 Rest of the World DHS Market, by Region, 2017–2027 (US$ Mn)
TABLE 19 Becton, Dickinson and Company.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 20 Smiths Medical.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Terumo Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Albert David Ltd..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Nipro Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 Medtronic plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Thermo Fisher Scientific.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Gerresheimer AG.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 B. Braun Medical Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Hindustan Syringes & Medical Devices Limited.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Changzhou Holinx Industries Co., Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 CODAN Medizinische Geräte GmbH & Co KG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 ISCON SURGICALS LTD.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)